Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices. 2016

Natalja Genina, and Jenny Holländer, and Harri Jukarainen, and Ermei Mäkilä, and Jarno Salonen, and Niklas Sandler
Pharmaceutical Sciences Laboratory, Abo Akademi University, Tykistökatu 6A, FI-20520, Turku, Finland; Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.

The main purpose of this work was to investigate the printability of different grades of ethylene vinyl acetate (EVA) copolymers as new feedstock material for fused-deposition modeling (FDM™)-based 3D printing technology in fabrication of custom-made T-shaped intrauterine systems (IUS) and subcutaneous rods (SR). The goal was to select an EVA grade with optimal properties, namely vinyl acetate content, melting index, flexural modulus, for 3D printing of implantable prototypes with the drug incorporated within the entire matrix of the medical devices. Indomethacin was used as a model drug in this study. Out of the twelve tested grades of the EVA five were printable. One of them showed superior print quality and was further investigated by printing drug-loaded filaments, containing 5% and 15% indomethacin. The feedstock filaments were fabricated by hot-melt extrusion (HME) below the melting point of the drug substance and the IUS and SR were successfully printed at the temperature above the melting point of the drug. As a result, the drug substance in the printed prototypes showed to be at least partly amorphous, while the drug in the corresponding HME filaments was crystalline. This difference affected the drug release profiles from the filaments and printed prototype products: faster release from the prototypes over 30days in the in vitro tests. To conclude, this study indicates that certain grades of EVA were applicable feedstock material for 3D printing to produce drug-loaded implantable prototypes.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007434 Intrauterine Devices Contraceptive devices placed high in the uterine fundus. Contraceptive Devices, Intrauterine,Contraceptive IUD,Contraceptive IUDs,IUD, Unmedicated,Unmedicated IUDs,Contraceptive Device, Intrauterine,Device, Intrauterine,Device, Intrauterine Contraceptive,Devices, Intrauterine,Devices, Intrauterine Contraceptive,IUD, Contraceptive,IUDs, Contraceptive,Intrauterine Contraceptive Device,Intrauterine Contraceptive Devices,Intrauterine Device,Unmedicated IUD
D011145 Polyvinyls POLYMERS derived from the monomer VINYL COMPOUNDS. Polyvinyl
D002152 Calorimetry, Differential Scanning Differential thermal analysis in which the sample compartment of the apparatus is a differential calorimeter, allowing an exact measure of the heat of transition independent of the specific heat, thermal conductivity, and other variables of the sample. Differential Thermal Analysis, Calorimetric,Calorimetric Differential Thermal Analysis,Differential Scanning Calorimetry,Scanning Calorimetry, Differential
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D012212 Rheology The study of the deformation and flow of matter, usually liquids or fluids, and of the plastic flow of solids. The concept covers consistency, dilatancy, liquefaction, resistance to flow, shearing, thixotrophy, and VISCOSITY. Flowmetry,Velocimetry,Velocimetries
D014783 Viscosity The resistance that a gaseous or liquid system offers to flow when it is subjected to shear stress. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Viscosities
D014961 X-Ray Diffraction The scattering of x-rays by matter, especially crystals, with accompanying variation in intensity due to interference effects. Analysis of the crystal structure of materials is performed by passing x-rays through them and registering the diffraction image of the rays (CRYSTALLOGRAPHY, X-RAY). (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Xray Diffraction,Diffraction, X-Ray,Diffraction, Xray,Diffractions, X-Ray,Diffractions, Xray,X Ray Diffraction,X-Ray Diffractions,Xray Diffractions
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D065546 Drug Liberation Release of drugs from DOSAGE FORMS into solution. Drug Dissolution,Drug Release,Dissolution, Drug,Liberation, Drug,Release, Drug

Related Publications

Natalja Genina, and Jenny Holländer, and Harri Jukarainen, and Ermei Mäkilä, and Jarno Salonen, and Niklas Sandler
April 2024, Drug development and industrial pharmacy,
Natalja Genina, and Jenny Holländer, and Harri Jukarainen, and Ermei Mäkilä, and Jarno Salonen, and Niklas Sandler
September 2017, Journal of controlled release : official journal of the Controlled Release Society,
Natalja Genina, and Jenny Holländer, and Harri Jukarainen, and Ermei Mäkilä, and Jarno Salonen, and Niklas Sandler
November 2022, Viruses,
Natalja Genina, and Jenny Holländer, and Harri Jukarainen, and Ermei Mäkilä, and Jarno Salonen, and Niklas Sandler
December 2018, International journal of pharmaceutics,
Natalja Genina, and Jenny Holländer, and Harri Jukarainen, and Ermei Mäkilä, and Jarno Salonen, and Niklas Sandler
January 2002, Journal of materials science. Materials in medicine,
Natalja Genina, and Jenny Holländer, and Harri Jukarainen, and Ermei Mäkilä, and Jarno Salonen, and Niklas Sandler
November 2023, Polymers,
Natalja Genina, and Jenny Holländer, and Harri Jukarainen, and Ermei Mäkilä, and Jarno Salonen, and Niklas Sandler
June 2018, International journal of pharmaceutics,
Natalja Genina, and Jenny Holländer, and Harri Jukarainen, and Ermei Mäkilä, and Jarno Salonen, and Niklas Sandler
May 2018, Journal of controlled release : official journal of the Controlled Release Society,
Natalja Genina, and Jenny Holländer, and Harri Jukarainen, and Ermei Mäkilä, and Jarno Salonen, and Niklas Sandler
September 2017, Expert review of medical devices,
Natalja Genina, and Jenny Holländer, and Harri Jukarainen, and Ermei Mäkilä, and Jarno Salonen, and Niklas Sandler
December 2006, Journal of materials science. Materials in medicine,
Copied contents to your clipboard!